Preoperative Noncoronary Cardiovascular Assessment and Management of Kidney Transplant Candidates

Area of Science:

• Nephrology
• Cardiology
• Transplantation

Background:

• Pretransplant risk assessment for kidney transplant candidates with end-stage kidney disease (ESKD) is complex.
• Cardiovascular disease (CVD) is a major concern in ESKD patients undergoing kidney transplantation.
• Altered cardiovascular physiology in ESKD includes volume shifts, calcium-phosphate dysregulation, and cardiac remodeling.

Purpose of the Study:

• To provide a contemporary review of cardiovascular challenges in the ESKD population.
• To highlight the need for an evidence-based model for pretransplant cardiovascular risk assessment in ESKD.
• To consolidate current knowledge on specific cardiovascular conditions relevant to kidney transplant candidates.

Main Methods:

• Literature review focusing on cardiovascular complications in ESKD.
• Analysis of factors influencing cardiovascular health in patients with end-stage kidney disease.
• Synthesis of evidence regarding cardiomyopathy, pulmonary hypertension, valvular dysfunction, and arrhythmias.

Main Results:

• Cardiovascular disease presents unique challenges in ESKD patients.
• Specific conditions like cardiomyopathy/heart failure, pulmonary hypertension, valvular dysfunction, and arrhythmias are prevalent.
• Understanding these ESKD-specific cardiovascular risk profiles is crucial.

Conclusions:

• A consolidated, evidence-based model is needed for pretransplant cardiovascular risk assessment in ESKD.
• Addressing the unique cardiovascular challenges in ESKD patients can optimize transplant outcomes.
• Further research into ESKD-specific cardiovascular risk is warranted.